Trials / Terminated
TerminatedNCT03375606
Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous CSL730 in Healthy Caucasian and Japanese Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- CSL Behring · Industry
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety and tolerability of ascending doses of CSL730 after a single intravenous (IV) infusion in healthy Caucasian and Japanese subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CSL730 | Solution for IV infusion |
| OTHER | Placebo | Saline solution for IV infusion |
Timeline
- Start date
- 2018-01-10
- Primary completion
- 2020-06-22
- Completion
- 2020-06-22
- First posted
- 2017-12-18
- Last updated
- 2021-06-03
Locations
2 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT03375606. Inclusion in this directory is not an endorsement.